Advanced search
Publication Cover
Expert Opinion on Medical Diagnostics Volume 3, 2009 - Issue 5
Journal homepage
25
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Physiological and pathophysiological roles of placental aminopeptidase in maternal sera: possible relation to preeclampsia and preterm delivery

Shigehiko Mizutani Daiya Building Ladys' Clinic, 1F, No.2, 3-15-1, Meieki, Nakamura-ku, Nagoya, 450-0002, Japan
, MD PhD,
Katsuhiko Naruse Nara Medical University, Department of Obstetrics and Gynecology, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan +81 744 29 8847; +81 744 23 6557; [email protected]
, MD PhD,
Akira Hattori Laboratory of Cellular Biochemistry, RIKEN, 2-1 Hirosawa, Wako-shi, 351-0198, Saitama, Japan
, PhD,
Masafumi Tsujimoto Laboratory of Cellular Biochemistry, RIKEN, 2-1 Hirosawa, Wako-shi, 351-0198, Saitama, Japan
, PhD &
Hiroshi Kobayashi Nara Medical University, Department of Obstetrics and Gynecology, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan +81 744 29 8847; +81 744 23 6557; [email protected]
, MD PhD
Pages 479-491 | Published online: 29 Jul 2009

Bibliography

  • Goldblatt H, Kahn JR, Hanzal RF. Studies on experimental hypertension.IX.The effect on the blood pressure of constriction of the abdominal aorta above and below the site of origin of both main renal arteries. J Exp Med 1939;69:649-74
  • Mangos GJ. Cardiovascular disease following preeclampsia: understanding the mechanisms. J Hyperten 2006;24:639-41
  • Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83
  • Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008;21:9-23
  • Mutter WP, Karumanchi SA. Molecular mechanisms of preeclampsia. Microvasc Res 2008;75:1-8
  • Chafetz I, Kuhnreich I, Sammar M, et al. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2007;197:35.e1-7
  • Than NG, Romero R, Hillermann R, et al. Prediction of preeclampsia – a workshop report. Placenta 2008;29(Suppl A):S83-5
  • Creasy RK, Resnik R, Iams JD. Maternal-fetal medicine: principles and practice, Fifth edition, Chapter 34. Preterm labor and delivery. Elsevier, Inc.: USA; 2004. p. 623-61
  • Creasy RK. Preterm birth prevention: where are we? Am J Obstet Gynecol 1993;168:1223-30
  • Bernal AL. Overview of current research in parturition. Exp Physiol 2001;86:213-22
  • Iams JD, Goldenbaerg RI, Mercer BM, et al. The preterm prediction study: Can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol 2001;184:652-5
  • Barker DJ. Maternal nutrition, fetal nutrition, and disease in later life. Nutrition 1997;13:807-13
  • Herschel M, Mittendorf R. Tocolytic magnesium sulfate toxicity and unexpected neonatal death. J Perinatol 2001;21:261-2
  • Fletcher SE, Fyfe DA, Case CL, et al. Myocardial necrosis in a newborn after long-term maternal subcutaneous terubutaline infusion for suppression of preterm labor. Am J Obstet Gynecol 1991;165:1401-4
  • Kreider ML, Seidler FJ, Slotkin TA. β-Adrenoreceptor modulation of transiently overexpressed β2-adrenoreceptors in brain and peripheral tissues: cellular mechanisms underlying the developmental toxicity of terbutaline. Brain Res Bull 2004;62:305-14
  • Iwasaki Y, Kinoshita M, Ikeda K, et al. Trophic effect of angiotensin II, vasopressin and other peptides on the cultured ventral spinal cord of rat embryo. J Neurol Sci 1991;103:151-5
  • Ervin MG, Kullama LK, Ross MG, et al. Vasopressin receptors and effects during fetal development. Reg Peptide 1993;45:203-8
  • Broughton Pipkin F, Symonds EM. Factors affecting angiotensin II concentrations in the human infant at birth. Clin Sci Mol Med 1977;52:449-56
  • Oosterbaan HP, Swaab DF. Amniotic oxytocin and vasopressin in relation to human fetal development and labour. Early Hum Dev 1989;19:253-62
  • Kingdam JC, McQueen J, Connell JM, et al. Fetal angiotensin II levels and vascular (type II) angiotensin receptors in pregnancies complicated by intrauterine growth retardation. Br J Obstet Gynaecol 1993;100:476-82
  • Diczfaulsy E. Endocrine functions of the human fetoplacental unit. Fed Proc 1964;23:791-8
  • Mizutani S, Tomoda Y. Effects of placental proteases on maternal and fetal blood pressure in normal pregnancy and preeclampsia. Am J Hypertens 1996;9:591-7
  • Mizutani S, Okano K, Hasegawa E, et al. Aminopeptidase A in human placenta. Biochim Biophs Acta 1981;678:168-70
  • Taira H, Mizutani S, Narita O, et al. Angiotensin II-converting enzyme in human placenta. Placenta 1985;6:543-9
  • Yagami H, Kurauchi O, Murata Y, et al. Expression of angiotensin converting enzyme in human placenta and its physiologic role in the fetal circulation. Obstet Gynecol 1994;84:453-7
  • Raasch W, Johren O, Schwarz S, et al. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR. J Hypertens 2004;22:611-8
  • Boschmann M, Kreuzberg U, Engeli S, et al. The effect of oral glucose loads on tissue metabolism during angiotensin II receptor and beta-receptor blockade in obese hypertensive subjects. Horm Metab Res 2006;38:323-9
  • Mizutani S, Akiyama H, Kurauchi O, et al. In vitro degradation of angiotensin II (A-II) by human placental subcellular fractions, pregnancy sera and purified placental aminopeptidases. Acta Endocrinol 1985;110:135-9
  • Wolf G, Mentzel S, Assmann KJ. Aminopeptidase A: a key enzyme in the intrarenal degradation of angiotensin II. Exp Nephrol 1997;5:364-9
  • Mizutani S, Ishii M, Hattori A, et al. New insight into the importance of aminopeptidase A in hypertension. Heart Fail Rev 2008;13:273-84
  • Gafford JT, Skidgel RA, Erdos EG, et al. Human kidney “enkephalinase”, a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 1983;22:3265-71
  • Walter R, Simmons WH, Yoshimoto T. Proline specific endo-and exopeptidases. Mol Cell Biochem 1980;30:111-27
  • Tipnis SR, Hooper NM, Hyde R, et al. A human homolog of Angiotensin-converting enzyme. cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000;275:33238-43
  • Mitsui T, Nomura S, Okada M, et al. Hypertension and Angiotensin II hypersensitivity in aminopeptidase A-deficient mice. Mol Med 2003;9:57-62
  • Arias F, Tomich P. Etiology and outcome of low birth weight and preterm infants. Obstet Gynecol 1982;60:277-81
  • Liggins GC, Kennedy PC, Holm LW. Failure of initiation of parturition after electrocoagulation of the pituitary of the foetal lamb. Am J Obstet Gynecol 1967;98:1080-6
  • Liggins GC, Grieves SA, Kendall JZ, et al. The physiological roles of progesterone, oestradiol-17β and prostaglandin F2α in the control of ovine parturition. J Reprod Fert 1972;16(Suppl):85-104
  • Chard T, Hudson CN, Edwards CR, et al. Release of oxytocin and vasopressin by the human foetus during labour. Nature 1971;234:352-4
  • Blanks AM, Thornton S. The role of oxytocin in parturition. BJOG 2003;110(Suppl 20):46-51
  • Fuchs AR, Fuchs F, Husslein P, et al. Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 1984;150:734-41
  • Mizutani S, Tomoda Y. Oxytocinase: placental cystine aminopeptidase or placental leucine aminopeptidase (P-LAP). Sem Reprod Endocrinol 1992;10:146-53
  • Mizutani S, Sumi O, Oka K, et al. In vitro degradation of oxytocin by pregnancy serum, placental subcellular fractions and purified placental aminopeptidases. Exp Clin Endocrinol 1985;86:310-6
  • Naruki M, Mizutani S, Goto K, et al. Oxytocin is hydrolyzed by an enzyme in human placenta that is identical to the oxytocinase of pregnancy serum. Peptides 1996;17:257-61
  • Mizutani S, Yoshino M, Oya M. Placental and non-placental leucine aminopeptidases during normal pregnancy. Clin Biochem 1976;9:16-8
  • Yamahara N, Nomura S, Suzuki T, et al. Placental leucine aminopeptidase/oxytocinase in maternal serum and placenta during normal pregnancy. Life Sci 2000;66:1401-10
  • Klimek M, Wicherek L, Popiela TJ. Changes of maternal ACTH and oxytocinase plasma concentrations during the first trimester of spontaneous abortion. Neuroendocrinol Lett 2005;26:342-6
  • Wicherek L, Dutsch-Wicherek M, Mak P. The role of RCAS1 and oxytocinase in immune tolerance during pregnancy. Fetal Diagn Ther 2005;20:420-5
  • Nagasaka T, Nomura S, Okamura M, et al. Immunohistochemical localization of placental leucine aminopeptidase/oxytocinase in normal human placental, fetal and adult tissues. Reprod Fertil Dev 1997;9:747-53
  • Richter ON, Dorn C, van de vondel P, et al. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy. Arch Gynecol Obstet 2005;272:26-30
  • Engstrom T, Bratholm P, Vilhardt H, et al. Effect of oxytocin receptor and beta2-adrenoreceptor blockade on myometrial oxytocin receptors in parturient rats. Biol Reprod 1999;60:322-9
  • Gant NF, Daley GL, Chand S, et al. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest 1973;52:2682-9
  • Conrad KP, Colpoys MC. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. J Clin Invest 1986;77:236-45
  • Caldeyro-Barcia R, Theobald GW. Sensitivity of the pregnant human myometrium to oxytocin. Am J Obstet Gynecol 1968;102:1181
  • Mizutani S, Ito Y, Nomura S, et al. Increased sensitivity to bradykinin in pregnant rats. Res Commun Chem Pathol Pharmacol 1989;64:373-80
  • Marceau F, Lussier A, Regoli D, et al. Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen Pharm 1983;14:209-29
  • Ito Y, Mizutani S, Kurauchi O, et al. Purification and properties of microsomal carboxypeptidase N (kininase I) in human placenta. Enzyme 1989;42:8-14
  • Nakashima Y, Ohno Y, Itakura A, et al. Possible involvement of aminopeptidase A in hypertension in spontaneously hypertensive rats (SHRs) and change of refractoriness in response to angiotensin II in pregnant SHRs. J Hypertens 2002;20:2233-8
  • Ishii M, Naruse K, Hattori A, et al. Oxytocin hypersensitivity in pregnant P-LAP deficient mice. Life Sci 2009;84:668-72
  • Asada Y, Mizutani S, Kasugai M, et al. Relationship between the changes in placental blood flow resistance assessed by Doppler technique and maternal serum placental aminopeptidases, which degrade vaso-active peptides, in pre-eclampsia. Horm Metab Res 1992;24:342-4
  • Campbell SJ, Diaz-Recasens DR, Griffin TE, et al. New Doppler technique for assessing uteroplacental blood flow. Lancet 1983;321:675-7
  • Mizutani S, Akiyama H, Kurauchi O, et al. Plasma angiotensin II and serum placental leucine aminopeptidase (P-LAP) in pre-eclampsia. Arch Gynecol 1985;236:165-72
  • Mohamed SA, Mizutani S, Salem HT, et al. Changes of placental proteases, which degrade vasoactive peptides, in maternal sera at the onset of preeclampsia. Med Sci Res 1995;23:123-6
  • Oney T, Kaulhausen H. The value of the angiotensin sensitivity test in the early diagnosis of hypertensive disorders in pregnancy. Am J Obstet Gynecol 1982;142:17-20
  • Mizutani S, Yamada R, Kurauchi O, et al. Serum aminopeptidase A (APA) in normal pregnancy and pregnancy complicated by pre-eclampsia. Arch Gynecol 1987;240:27-31
  • Than NG, Abdul Rahman O, Magenheim R, et al. Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Arch 2008;453:387-400
  • Alexander DP, Forsling ML, Martin MS, et al. The effect of maternal hypoxia on fetal pituitary hormone release in the sheep. Biol Neonate 1972;21:219-28
  • Tsujimoto M, Mizutani S, Adachi M, et al. Idetification of human placental leucine aminopeptidase as oxytocinase. Arch Biochem Biophys 1992;292:388-92
  • Hariyama Y, Itakura A, Okamura M, et al. Placental aminopeptidase A as a possible barrier of angiotensin II between mother and fetus. Placenta 2000;21:621-7
  • Kimura T, Tanizawa O, Mori K, et al. Structure and expression of a human oxytocin receptor. Nature 1992;356:526-9
  • Mizutani S, Hayakawa H, Akiyama H, et al. Simultaneous determinations of plasma oxytocin and serum placental leucine aminopeptidase (P-LAP) during late pregnancy. Clin Biochem 1982;15:141-5
  • Kozaki H, Itakura A, Okamura M, et al. Maternal serum placental leucine aminopeptidase (P-LAP)/oxytocinase and preterm delivery. Int J Gynec Obstet 2001;73:207-13
  • Johnson W, Albanese C, Handweger T, et al. Regulation of the human chorionic gonadotrophin alpha-and beta-subunit promoters by AP-2. J Biol Chem 1997;272:15405-12
  • Richardson BD, Langland RA, Bachurski CJ, et al. Activator protein-2 regulates human placental lactogen gene expression. Mol Cell Endocrinol 2000;160:183-92
  • Chou JY. Effects of adenosine cyclic nucleotides on the synthesis of human placental cells. Cancer Res 1980;40:4025-30
  • Feinman MA, Kliman HJ, Caltabiano S, et al. 8-Bromo-3',5'-adenosine monophosphate stmulates the endocrine activity of human cytotrophoblasts in culture. J Clin Endocrinol Metab 1986;63:1211-7
  • Rogi T, Tsujimoto M, Nakazato H, et al. Human placental leucine aminopeptidase/oxytocinase: a new member of type II membrane-spanning zinc metallopeptidase family. J Biol Chem 1996;271:56-61
  • Horio J, Nomura S, Okada M, et al. Structural organization of the 5'-end and chromosomal assignment of human placental leucine aminopeptidase/insulin-regulated membrane aminopeptidase gene. Biochem Biophys Res Commun 1999;262:269-74
  • Iwase A, Nomura S, Mizutani S. Characterization of a secretase activity for placental leucine aminopeptidase. Arch Biochem Biophys 2001;393:163-9
  • Ito N, Nomura S, Iwase A, et al. ADAMs, a disintegrin and metalloproteinases, mediate shedding of oxytocinase. Biochem Biophys Res Commun 2004;314:1008-13
  • Gilpin BJ, Loechel F, Mattei MG, et al. A novel secreted form of human ADAM 12 (meltrin alpa) provokes myogenesis in vivo. J Biol Chem 1998;273:157-66
  • Loechel F, Fox JW, Murphy G, et al. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun 2000;278:511-5
  • Laigaard J, Sorensen T, Placing S, et al. Reduction of disintegrin and metalloprptease ADAM 12 in preeclampsia. Obstet Gynecol 2005;106:144-9
  • Gack S, Marme A, Marme F, et al. Preeclampsia: increased expression of soluble ADAM 12. J Mol Med 2005;83:887-96
  • Ito T, Nomura S, Okada M, et al. Transcriptional regulation of human placental leucine aminopeptidase/oxytocinase gene. Mol Hum Reprod 2001;7:887-94
  • Ito T, Nomura S, Okada M, et al. AP-2 and Ikaros regulate transcription of human placental leucine aminopeptidase/oxytocinase gene. Biochem Biophys Res Commun 2002;290:1048-53
  • Georgopoulos K, Moore DD, Derfler B. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 1992;258:808-12
  • Wang J, Walker Q, Lin Q, et al. The mouse BP-1 gene: structure, chromosomal localization, and regulation of expression by type II interferons and interleukin-7. Genomics 1996;33:167-76
  • Iwanaga K, Nomura S, Ito T, et al. Placental leucine aminopeptidase/oxytocinase gene regulation by activator protein-2 in BeWo cell model of human trophoblast differentiation. FEBS Lett 2003;552:120-4
  • Bimbaumer M. Vasopressin receptors. Trends Endocrinol Metab 2000;11:406-10
  • Hillier SL, Witkin SS, Krohn MA, et al. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol 1993;81:941-8
  • Menon R, Swan KF, Lyden TW, et al. Expression of inflammatory 2 membranes. Am J Obstet Gynecol 1995;172:493-500
  • Ikoma Y, Nomura S, Ito T, et al. Interleukin-1β stimulates placental leucine aminopeptidase/oxytocinase expression in BeWo choriocarcinoma cells. Mol Hum Reprod 2003;9:103-10
  • Ino K, Uehara C, Kikkawa F, et al. Enhancement of aminopeptidase A expression during angiotensin II-induced choriocarcinoma cell proliferation through AT1 receptor involving protein kinase C-and mitogen-activated protein kinase-dependent signaling pathway. J Clin Endocrinol Metab 2003;88:3973-82
  • Johnson MP, Fitzpatrick E, Dyer TD, et al. Idetification of two novel quantitative trait for pre-eclampsia susceptibility on chromosome 5q and 13q using a variance components-based linkage approach. Mol Hum Reprod 2007;13:61-7
  • Hattori A, Matsumoto H, Mizutani S, et al. Molecular cloning of adipocyte-derived leucine aminopeptidase highly related to placental leucine aminopeptidase/oxytocinase. J Biochem (Tokyo) 1999;125:931-8
  • Quan A. Fetopathy associated with expousure to Angiotensin converting enzyme inhibitors and Angiotensin receptor antagonists. Early Hum Dev 2006;82:23-8
  • Binder ND, Anderson DF. Plasma rennin activity responses to graded decreases in renal perfusion pressure in fetal and newborn lambs. Am J Physiol 1992;262:R524-R9
  • Toyo-Oka T, Kawada T, Nakata J, et al. Translocation and cleavage of myocardial dystrophin as a common pathway to advanced heart failure: a scheme for the progression of myocardial dysfunction. Proc Natl Acad Sci USA 2004;101:7381-5
  • Reversi A, Rimoldi V, Marrocco T, et al. The oxytocin receptor antagonist atosiban inhibits cell growth via a “biased agonist” mechanism. J Biol Chem 2005;280:16311-8
  • Mizutani S, Shibata K, Kikkawa F, et al. Essential role of placental leucine aminopeptidase in gynecologic malignancy. Expert Opin Ther Targets 2007;11:453-61
  • Ishii M, Hattori A, Numaguchi Y, et al. The effects of recombinant aminopeptidase A on hypertension in spontaneously hypertensive rats: its effect in comparison with candesartan. Horm Metab Res 2008;40:887-91

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.